Abstract
Familial hypobetalipoproteinemia (FHBL) is an apparently autosomal dominant disorder of lipid metabolism characterized by less than fifth percentile age- and sex-specific levels of apolipoprotein beta (apobeta) and low-density lipoprotein-cholesterol. In a minority of cases, FHBL is due to truncation-producing mutations in the apobeta gene on chromosome 2p23-24. Previously, we reported on a four-generation FHBL kindred in which we had ruled out linkage of the trait to the apobeta gene. To locate other loci containing genes for low apobeta levels in the kindred, a genomewide search was conducted. Regions on 3p21.1-22 with two-point LOD scores >1.5 were identified. Additional markers were typed in the region of these signals. Two-point LOD scores in the region of D3S2407 increased to 3.35 at O = 0. GENEHUNTER confirmed this finding with an nonparametric multipoint LOD score of 7.5 (P=.0004). Additional model-free analyses were conducted with the square root of the apobeta level as the phenotype. Results from the Loki and SOLAR programs further confirmed linkage of FHBL to 3p21.1-22. Weaker linkage to a region near D19S916 was also indicated by Loki and SOLAR. Thus, a heretofore unidentified genetic susceptibility locus for FHBL may reside on chromosome 3.
MeSH Terms
Adolescent
Aged
Apolipoproteins B/blood,genetics
Chromosome Mapping
Chromosomes, Human, Pair 3/genetics
Female
Genetic Markers/genetics
Genetic Predisposition to Disease/genetics
Haplotypes/genetics
Humans
Hypobetalipoproteinemias/blood,genetics
Lod Score
Male
Middle Aged
Models, Genetic
Pedigree
Quantitative Trait, Heritable
Software
Chemicals
Apolipoproteins B
Genetic Markers
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Yuan B
Washington University School of Medicine, Washington University, St. Louis, MO 63110, USA.
Neuman R
Duan S H
Weber J L
Kwok P Y
Saccone N L
Wu J S
Liu K Y
Schonfeld G
References (16)
16 references, click to expand
-
Apolipoprotein B gene mutations affecting cholesterol levels.
J Intern Med. 1992 Jun;231(6):643-52
PMID: 1619387
-
Known mutations of apoB account for only a small minority of hypobetalipoproteinemia.
J Lipid Res. 1999 May;40(5):955-9
PMID: 10224165
-
Evidence for a dominant gene that suppresses hypercholesterolemia in a family with defective low density lipoprotein receptors.
J Clin Invest. 1989 Aug;84(2):656-64
PMID: 2760205
-
A form of familial hypobetalipoproteinaemia not due to a mutation in the apolipoprotein B gene.
J Intern Med. 1991 Jan;229(1):41-7
PMID: 1995762
-
Faster sequential genetic linkage computations.
Am J Hum Genet. 1993 Jul;53(1):252-63
PMID: 8317490
-
The hypobetalipoproteinemias.
Annu Rev Nutr. 1995;15:23-34
PMID: 8527219
-
Reference intervals for plasma apolipoprotein B determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study.
Clin Chem. 1996 Apr;42(4):515-23
PMID: 8605667
-
Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics.
Am J Hum Genet. 1996 Jun;58(6):1323-37
PMID: 8651310
-
Parametric and nonparametric linkage analysis: a unified multipoint approach.
Am J Hum Genet. 1996 Jun;58(6):1347-63
PMID: 8651312
-
Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B.
Gastroenterology. 1996 Oct;111(4):1125-33
PMID: 8831609
-
Genetic heterogeneity in familial hypobetalipoproteinemia: linkage and non-linkage to the apoB gene in Caucasian families.
Am J Med Genet. 1998 Feb 26;76(1):79-86
PMID: 9508071
-
Multipoint quantitative-trait linkage analysis in general pedigrees.
Am J Hum Genet. 1998 May;62(5):1198-211
PMID: 9545414
-
Frequency of ApoB and ApoE gene mutations as causes of hypobetalipoproteinemia in the framingham offspring population.
Arterioscler Thromb Vasc Biol. 1998 Nov;18(11):1745-51
PMID: 9812913
-
Asymptomatic elevation of aminotransferase levels and fatty liver secondary to heterozygous hypobetalipoproteinemia.
Am J Gastroenterol. 1998 Dec;93(12):2598-9
PMID: 9860439
-
Multipoint oligogenic analysis of age-at-onset data with applications to Alzheimer disease pedigrees.
Am J Hum Genet. 1999 Mar;64(3):839-51
PMID: 10053019
-
Cholesterol and mortality. 30 years of follow-up from the Framingham study.
JAMA. 1987 Apr 24;257(16):2176-80
PMID: 3560398